The 2025 EASL-AASLD Masterclass is a unique opportunity for early-stage investigators in academic hepatology to take their careers to the next level. This two-day intensive training session will bring together clinical, basic, and translational scientists from leading academic medical institutions…
This EASL School is dedicated to management of liver disease in pregnancy and will be delivered by world-leaders in the field. Focused on the topics covered in the recently published EASL Clinical Practice Guidelines on the management of liver disease…
Hepatology, HPB Surgery and Transplant patients will spend time in the Critical Care environment, either as an emergency or as part of elective treatment. All hepatologists need to be familiar with the critical care environment in order to work along-side…
This interactive School will be held at the historic and internationally renowned University of Oxford, UK, within the Nuffield Department of Medicine – the largest department in biomedicine in Europe. This School will introduce participants to advanced immunological techniques as…
The 2024 AASLD-EASL Masterclass is a unique opportunity for early-stage investigators in academic hepatology to take their careers to the next level. This two-day intensive training session will bring together clinical, basic, and translational scientists from leading academic medical institutions…
Many of the limitations of cellular and animal models of liver disease can be overcome by using human precision cut liver slices and liver organoid cultures. These cutting-edge 3D models can recapitulate the complex multi-cellular pathways involved in liver injury and disease progression. In this Basic Science EASL school, each participant…
A few decades ago it was common that experienced hepatologists had a major role in the interpretation of liver biopsy findings; in some cases the liver pathologist was indeed a clinician. The combination of clinical expertise and knowledge in pathology…
After years of stagnation, a paradigm shift has occurred in the therapy of hepatobiliary malignancies: immune-oncology based combinations and new options in the second line revolutionized the treatment of patients with hepatocellular carcinoma, while biliary cancers - endowed with a…
Steatotic Liver Disease (SLD) is proposed to be the most prevalent liver disease Worldwide due to the close association with the metabolic syndrome and epidemic of obesity and type 2 diabetes. End-stage liver disease, development of hepatocellular carcinoma and increased…
This school will focus on the contribution of gut-liver axis to a range of chronic liver diseases, the growing pertinence of antimicrobial resistance to cirrhosis, and manipulation of the gut microbiome as a novel approach to treatment (using faecal microbiota…